NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
ObsEva SA (NASDAQ: OBSV)
OBSV Technical Analysis
5
As on 24th Apr 2023 OBSV STOCK Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.40 & Strong Sell for SHORT-TERM with Stoploss of 2.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OBSVSTOCK Price
Open | 0.08 | Change | Price | % |
High | 0.10 | 1 Day | 0.00 | 0.00 |
Low | 0.08 | 1 Week | -0.01 | -11.11 |
Close | 0.08 | 1 Month | -0.07 | -46.67 |
Volume | 128096 | 1 Year | -2.44 | -96.83 |
52 Week High 2.58 | 52 Week Low 0.08 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
OBSV Daily Charts |
OBSV Intraday Charts |
Whats New @ Bazaartrend |
OBSV Free Analysis |
|
OBSV Important Levels Intraday
RESISTANCE | 0.12 |
RESISTANCE | 0.11 |
RESISTANCE | 0.10 |
RESISTANCE | 0.09 |
SUPPORT | 0.07 |
SUPPORT | 0.06 |
SUPPORT | 0.05 |
SUPPORT | 0.04 |
OBSV Forecast May 2024
4th UP Forecast | 1 |
3rd UP Forecast | 0.71 |
2nd UP Forecast | 0.52 |
1st UP Forecast | 0.34 |
1st DOWN Forecast | -0.18 |
2nd DOWN Forecast | -0.36 |
3rd DOWN Forecast | -0.55 |
4th DOWN Forecast | -0.84 |
OBSV Weekly Forecast
4th UP Forecast | 0.47 |
3rd UP Forecast | 0.34 |
2nd UP Forecast | 0.27 |
1st UP Forecast | 0.19 |
1st DOWN Forecast | -0.03 |
2nd DOWN Forecast | -0.11 |
3rd DOWN Forecast | -0.18 |
4th DOWN Forecast | -0.31 |
OBSV Forecast2024
4th UP Forecast | 5.13 |
3rd UP Forecast | 3.51 |
2nd UP Forecast | 2.51 |
1st UP Forecast | 1.51 |
1st DOWN Forecast | -1.35 |
2nd DOWN Forecast | -2.35 |
3rd DOWN Forecast | -3.35 |
4th DOWN Forecast | -4.97 |
ObsEva SA ( NASDAQ USA Symbol : OBSV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OBSV Other Details
Segment | EQ | |
Market Capital | 200332528.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
OBSV Address
OBSV Latest News
OBSV Business Profile
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. Address: Chemin des Aulx, 12, Geneva, Switzerland, 1228
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service